Atlas Trials

Rznomics, Inc.

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Rznomics, Inc.

RecordFirmDate
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma (NCT06695026)Rznomics, Inc.2024-12-18
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma (NCT06102525)Rznomics, Inc.2024-10-08
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma (NCT05595473)Rznomics, Inc.2022-07-29

Track Rznomics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.